The purpose of this study is to investigate the effect of taurine on the plasma cholesterol concentration in genetic type 2 diabetic rats fed cholesterol-free or high-choles terol diets. Diabetic rats (GK male rats) and normal rats (Wistar male rats) were fed either a cholesterol-free or cholesterol-enriched (1% cholesterol+0.25% sodium cholate) diet sup plemented with or without 3% taurine for 21 or 14d. Compared to the normal rats, diabetic rats showed a high glucose concentration in their blood and plasma, but it was not affected by taurine feeding. The plasma insulin concentration was higher in the diabetic rats than in the normal rats. At the start of the experiment, the plasma cholesterol concentration was significantly higher in the diabetic rats than in the normal rats. Taurine did not affect the plasma cholesterol level in rats fed the cholesterol-free diet. However, taurine feeding signifi cantly increased the plasma HDL-cholesterol concentration in the diabetic rats fed the cho lesterol-free diet. In both the diabetic and normal rats fed the cholesterol diet, the plasma cholesterol concentration was significantly lower in rats fed the diet supplemented with tau rive than in the rats fed the control diet. It was concluded that taurine has a hypocholes terolemic effect in both diabetic and normal rats fed diets containing cholesterol. Moreover, these results suggest that taurine seems to affect the HDL-cholesterol metabolism in diabetic rats fed a cholesterol-free diet.
Biochemical analyses. The plasma cholesterol con centration was determined by an enzymatic method using a commercial kit (Cholesterol C-test, Wako, Osaka, Japan). The plasma (VLDL+LDL) fraction was precipitated with a heparin : manganese reagent (Wako) and the supernatant (the HDL fraction) was assayed for HDL-cholesterol using a commercial kit (HDL-cholesterol test, Wako). The concentration of (VLDL+LDL) cholesterol was calculated as the differ ence between the total plasma cholesterol concentra tion and the HDL cholesterol concentration. The plasma triglyceride and phospholipid concentrations were measured using commercial kits (Triglyceride G test and Phospholipid B test, respectively, Wako). The blood and plasma glucose concentrations were ana lyzed by commercial kits (TIDEX, Bayer Medical, Tokyo, Japan and Glucose CII test, Wako, respectively). The plasma insulin concentration was measured with an antibody-sandwich ELISA method using a "Lbis Rat Insulin" kit (Shibayagi, Gunma, Japan). The rat insulin supplied with the kit was used as the standard. The de termination range was 0.15 6-10ng/mL. rine treatment in the normal rats, except at 14d. The blood glucose concentration remained high in the dia betic rats throughout the experimental period as com pared to the normal rats, and was not affected by tau rine administration except on day 21. Table 2 shows the plasma concentrations of lipids, glucose, and insulin in the rats fed the cholesterol-free diets at 21d of the experiment. The total plasma choles terol concentration was significantly higher in the dia betic rats as compared to the normal rats (ANOVA analysis, p<0.001). When taurine was administered to the diabetic rats, the plasma cholesterol concentration increased (p<0.01), and this rise was due to the in crease in plasma HDL-cholesterol. The plasma triglyc eride concentration was significantly lower in the dia betic rats than in the normal rats (ANOVA analysis, p<0.001), and was significantly reduced by taurine feeding only in the normal rats (p<0.001). The plasma phospholipid concentration was higher in the diabetic rats than in the normal rats (ANOVA analysis, p<0.001). The plasma phospholipids were significantly higher in the diabetic rats fed taurine than in those fed the control diet (p<0.05). The plasma glucose and in sulin levels were significantly higher in the diabetic rats than in the normal rats (ANOVA analysis, p<0.001). However, the plasma glucose and insulin levels in the taurine-fed rats were not significantly different from the levels in the rats fed the taurine-free diet, except for the plasma glucose in the diabetic rats. No significant differ ence in liver cholesterol concentration was observed be tween the rats fed the taurine-free diets and taurine diets in both the normal and diabetic rats ( Table 3) .
The daily excretion of fecal bile acids was significantly greater in the normal rats than in the diabetic rats Table  5 ).
DISCUSSION
In the present study, at the start of the experiment, a high plasma cholesterol concentration was observed in the diabetic rats as compared to that of the normal rats, suggesting that the change in cholesterol metabolism was induced by the development of diabetes mellitus. In the diabetic rats, taurine feeding increased the HDL cholesterol, and also decreased the (VLDL+LDL) cholesterol concentration in the cholesterol-fed rats. From these results, it is suggested that taurine affects the cholesterol metabolism in diabetic rats. In a previous study, we found that taurine increased the HDL-cholesterol concentration in normal rats (6) and polychlorinated biphenyls-fed rats (18) . We also proved that taurine lowered the VLDL-cholesterol concentra tion in cholesterol-fed rats (5).
The present and previous studies (7, 8) show that taurine affects the plasma cholesterol concentration when the lipid metabolism is changed by diabetes melli tus. Luoma et al. reported that an alternation in the lipoprotein composition in the serum was observed in humans with NIDDM (19) . It is well known that the el evation of serum triglyceride (VLDL) and reduced HDL characterize the lipid profile in NIDDM (2, 3, 20) . To improve the lipoprotein profiles in serum by taurine in take seems to be effective for preventing diabetic hyper cholesterolemia.
The plasma cholesterol in diabetic GK rats fed the cholesterol-free diet was significantly elevated by tau rine feeding. This elevation depended on the HDL-frac tion. We previously observed that taurine intake raised the HDL-fraction in the serum in normal rats fed a cho lesterol-free diet (6) . Because apo A-I is the principal apolipoprotein consisting of HDL, the content of apo A-I may be related to the formation of HDL in the liver and the concentration of serum HDL-cholesterol (21) . In our previous study, the concentration of hepatic apo A-I mRNA tended to be greater in taurine-fed rats (6) . Therefore, in addition to normal rats, HDL-cholesterol concentration might be elevated through inducing ex Fig. 2 . Changes in plasma cholesterol concentration and blood glucose concentration in normal (line) and diabetic (bro ken line) rats fed high-cholesterol diets supplemented with or without 3% taurine (Experiment 2). Each point is the mean from six rats, and the vertical bars represent the SE. The experimental data were statistically analyzed by two-way ANOVA (16) . When the interaction (diabetesxtaurine) was significant (p<O.05), Student's t-test was performed (17 pression of the hepatic apo A-I gene by feeding taurine to type 2 diabetic rats fed a cholesterol-free as well. The plasma cholesterol fell from day 0 to 7 in all the groups fed the cholesterol-free diets. It is not clear how this phenomenon occurs. However, rats were not subjected to any stress as part of the experimental design and showed no visible signs of stress. It is well known that CYP7A1 contributes to the regulation of serum cholesterol concentration, espe cially (VLDL+LDL)-cholesterol concentration (5, 22) . However, there is little agreement on the change in hepatic CYP7A1 activity in diabetes, especially type 2 diabetes. CYP7A1 is an insulin-sensitive enzyme, and its activity is suppressed by insulin (23) . In the present study, the plasma insulin was higher in the diabetic rats. Fecal bile acid excretion, which positively corre lates with hepatic CYP7A1 activity (24) , was lower in the type 2 diabetic rats than in normal rats. A high level of plasma insulin from diabetes might suppress the he patic CYP7A1 activity. We previously reported that the reduction of (VLDL+LDL)-cholesterol through taurine intake was due to the enhancement of hepatic CYP7A1 activity and its gene expression (5 An accumulation of cholesterol in the liver was ob served in the cholesterol-fed diabetic rats. Therefore, cholesterol absorption from the small intestine in dia betic rats was surely unaffected compared to that of the normal rats. This different response may reflect the pe culiar metabolism of cholesterol in type 2 diabetic GK rats.
We previously observed that the VLDL fraction in serum lipoprotein was notably increased by cholesterol intake in normal and streptozotocin-induced diabetic rats (5, 8) , but not in GK rats in the present study. Compared to normal rats, the ability to release VLDL from the liver may be low, or the catabolism of VLDL fast, in GK rats. However, VLDL release is stimulated by insulin (20) , so lower (VLDL+LDL)-cholesterol in GK rats fed cholesterol seems not to be due to a change in VLDL release.
Insulin also promotes the activity of lipoprotein lipase (20, 25) . Therefore, the catabolism of VLDL may be faster in diabetic GK rats (high insulin) than in nor mal rats (normal insulin). The Otsuka Long-Evans Tokushima Fatty (OLETF) rat is also a type 2 diabetes model with high insulin and insulin resistance, but is obese. Nakaya et al. (26) reported that plasma choles terol and triglyceride are increased by cholesterol intake in OLETF rats. In the present study and the study of Nakaya et al. (26) , taurine feeding significantly de creased plasma (VLDL+LDL)-cholesterol. In our un published data, taurine suppressed VLDL release from the liver in cholesterol-fed normal rats administered Triton WR 1339. Therefore, taurine may be involved in the inhibition of VLDL release and/or the promotion of VLDL degradation.
Our results indicate that taurine has a plasma choles terol-lowering effect in genetic type 2 diabetic rats fed high-cholesterol diets as well as in normal rats, as re flected in the reduction of the (VLDL+LDL) fraction. It is suggested that taurine also affects the HDL-cholesterol metabolism in genetic type 2 diabetic rats.
